Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Congress Averts PAMA Cuts to Lab Test Rates for 2023

Move offers only a temporary halt to PAMA cuts to Medicare fees without more solid legislative action

CONGRESS ENACTED LEGISLATION LAST MONTH that suspends implementation of the next round of price cuts to the Medicare Part B Clinical Laboratory Fee Schedule (CLFS) that was scheduled to take effect on Jan. 1. This is a welcome development for the medical laboratory industry.  A two-paragraph inclusion in a 4,000- page, year-end government spending bill …

Congress Averts PAMA Cuts to Lab Test Rates for 2023 Read More »

To access this post, you must purchase The Dark Report.



You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

Privacy Policy: We will never share your personal information.